NCT06705062: Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
- State
- Under way
- Phase
- Phase 3
- People
- 316 planned
- Started
- 1 Jan 2025
- Primary completion
- 1 Dec 2027
- Arms
- Reduced dose of post-transplantation cyclophosphamide
- Results
- None posted
- 26 Nov 2024: Trial registered
- 1 Jan 2025: Trial started